|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
2 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
* To whom correspondence should be addressed. E-mail: afryer{at}jhsph.edu.
In the lungs, neuronal M2 muscarinic receptors inhibit acetylcholine release from the parasympathetic nerves. Parainfluenza virus infection causes loss of M2 receptor function, which increases acetylcholine release and vagally mediated bronchoconstriction. Since glucocorticoids are known to inhibit airway hyperresponsiveness, we tested whether dexamethasone (6.5 µg/kg or 65 µg/kg, i.p.) prevents virus-induced hyperresponsiveness and M2 receptor dysfunction in guinea pigs. In controls, pilocarpine, a muscarinic agonist, inhibited vagally induced bronchoconstriction, demonstrating functional M2 receptors. However, in virus-infected animals, pilocarpine failed to inhibit vagally induced bronchoconstriction demonstrating M2 receptor dysfunction. Frequency dependent bronchoconstriction was greater in virus infected than in controls, indicating airway hyperresponsiveness. Low dose dexamethasone (6.5 µg/kg i.p.) treatment prevented virus induced airway hyperresponsiveness, ameliorated M2R dysfunction, and decreased viral content in the lungs without inhibiting virus induced inflammation. High dose dexamethasone (65 µg/kg i.p.) prevented virus induced hyperresponsiveness, completely reversed M2 receptor dysfunction, decreased viral titers, and decreased virus induced inflammation. This high dose dexamethasone also increased M2 receptor function in uninfected animals. In conclusion, dexamethasone prevented virus induced hyperresponsiveness and M2 receptor dysfunction via multiple mechanisms.
This article has been cited by other articles:
![]() |
T. Xu, J. Qiao, L. Zhao, G. He, K. Li, J. Wang, Y. Tian, and H. Wang Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice Eur. Respir. J., April 1, 2009; 33(4): 852 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Saude, I. P. Obiefuna, R. L. Somorjai, F. Ajamian, C. Skappak, T. Ahmad, B. K. Dolenko, B. D. Sykes, R. Moqbel, and D. J. Adamko Metabolomic Biomarkers in a Model of Asthma Exacerbation: Urine Nuclear Magnetic Resonance Am. J. Respir. Crit. Care Med., January 1, 2009; 179(1): 25 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johnson Corticosteroids: Potential {beta}2-Agonist and Anticholinergic Interactions in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |